The Succinate Receptor as a Novel Therapeutic Target for Oxidative and Metabolic Stress-Related Conditions
Open accessAbstract
The succinate receptor (also known as GPR91) is a G protein-coupled receptor that is closely related to the family of P2Y purinoreceptors. It is expressed in a variety of tissues, including blood cells, adipose tissue, the liver, retina, and kidney. In these tissues, this receptor and its ligand succinate have recently emerged as novel mediators in local stress situations, including ischemia, hypoxia, toxicity, and hyperglycemia. Amongst others, the succinate receptor is involved in recruitment of immune cells to transplanted tissues. Moreover, it was shown to play a key role in the development of diabetic retinopathy. However, most prominently, the role of locally increased succinate levels and succinate receptor activation in the kidney, stimulating the systemic and local renin-angiotensin system, starts to unfold: the succinate receptor is a key mediator in the development of hypertension and possibly fibrosis in diabetes mellitus and metabolic syndrome. This makes the succinate receptor a promising drug target to counteract or prevent cardiovascular and fibrotic defects in these expanding disorders. Recent development of SUCNR1-specific antagonists opens novel possibilities for research in models for these disorders and may eventually provide novel opportunities for the treatment of patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previously, direct receptor-mediated anti-inflammatory effects of ACTH and succinate on immune cells associated with blockages of pro-inflammatory polarization have been shown.
“Previously, the direct receptor-mediated anti-inflammatory effects of ACTH and succinate on immune cells associated with blockages of pro-inflammatory polarization have been shown [51,52,89].”
From Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis (2021) · cites this paper as [89]
The section “Tissue Distribution and (Patho)Physiological Roles of SUCNR1” describes receptor-mediated effects of succinate on dendritic cells, but says succinate potentiates inflammatory cytokine production rather than blocking pro-inflammatory activity. “Future Perspectives” likewise says SUCNR1 signaling may increase inflammation. These passages do not address ACTH. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 43 · Cited by 211
Research works printed but not linked: 34
- Aguiar C. J. Andrade V. L. Gomes E. R. Alves M. N. Ladeira M. S. Pinheiro A. C. Gomes D. A. Almeida A. P. Goes A. M. Resende R. R. Guatimosim S. Leite M. F. (2010). Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 47, 37– 46 10.1016/j.ceca.2009.11.003 20018372 · DOI
- Bhuniya D. Umrani D. Dave B. Salunke D. Kukreja G. Gundu J. Naykodi M. Shaikh N. S. Shitole P. Kurhade S. De S. Majumdar S. Reddy S. B. Tambe S. Shejul Y. Chugh A. Palle V. P. Mookhtiar K. A. Cully D. Vacca J. Chakravarty P. K. Nargund R. P. Wright S. D. Graziano M. P. Singh S. B. Roy S. Cai T. Q. (2011). Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg. Med. Chem. Lett. 21, 3596– 3602 10.1016/j.bmcl.2011.04.091 21571530 · DOI · Paper page
- Brownlee M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615– 1625 10.2337/diabetes.54.6.1615 15919781 · DOI · Paper page
- Correa P. Kruglow E. Thompson M. Leite M. Dranoff J. Nathanson M. (2007). Succinate is a paracrine signal for liver damage. J. Hepatol. 47, 262– 269 10.1016/j.jhep.2007.03.016 17451837 PMC1986575 · DOI
- De Minicis S. Seki E. Uchinami H. Kluwe J. Zhang Y. Brenner D. A. Schwabe R. F. (2007) Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937– 1946 10.1053/j.gastro.2007.02.033 17484886 · DOI
- Dong X. Swaminathan S. Bachman L. A. Croatt A. J. Nath K. A. Griffin M. D. (2007). Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71, 619– 628 10.1038/sj.ki.5002132 17311071 · DOI
- Fedotcheva N. I. Sokolov A. P. Kondrashova M. N. (2006). Nonezymatic formation of succinate in mitochondria under oxidative stress. Free Radic. Biol. Med. 41, 56– 64 10.1016/j.freeradbiomed.2006.02.012 16781453 · DOI
- Gibala M. J. MacLean D. A. Graham T. E. Saltin B. (1998). Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise. Am. J. Physiol. 275, E235– E242 9688624
- Gnana-Prakasam J. P. Ananth S. Prasad P. D. Zhang M. Atherton S. S. Martin P. M. Smith S. B. Ganapathy V. (2011). Expression and iron-dependent regulation of succinate receptor GPR91 in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 52, 3751– 3758 10.1167/iovs.10-6722 21357408 PMC3109050 · DOI
- Hakak Y. Lehmann-Bruinsma K. Phillips S. Le T. Liaw C. Connolly D. T. Behan D. P. (2009). The role of the GPR91 ligand succinate in hematopoiesis. J. Leukoc. Biol. 85, 837– 843 10.1189/jlb.1008618 19204147 · DOI
- Hems D. A. Brosnan J. T. (1970). Effects of ischaemia on content of metabolites in rat liver and kidney in-vivo. Biochem. J. 120, 105 4321927 PMC1179573
- Hochachka P. W. Dressendorfer R. H. (1976). Succinate accumulation in man during exercise. Eur. J. Appl. Physiol. Occup. Physiol. 35, 235– 242 10.1007/BF00423282 976251 · DOI
- Hogberg C. Gidlof O. Tan C. Svensson S. Nilsson-Ohman J. Erlinge D. Olde B. (2011). Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-beta signaling. J. Thromb. Haemost. 9, 361– 372 10.1111/j.1538-7836.2010.04158.x 21143371 · DOI
- Jassem W. Heaton N. D. (2004). The role of mitochondria in ischemia//reperfusion injury in organ transplantation. Kidney Int. 66, 514– 517 10.1111/j.1523-1755.2004.761_9.x 15253700 · DOI
- Kohout T. A. Lefkowitz R. J. (2003). Regulation of g protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63, 9– 18 10.1124/mol.63.1.9 12488531 · DOI
- Kushnir M. M. Komaromy-Hiller G. Shushan B. Urry F. M. Roberts W. L. (2001). Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin. Chem. 47, 1993– 2002 11673368
- Macaulay I. C. Tijssen M. R. Thijssen-Timmer D. C. Gusnanto A. Steward M. Burns P. Langford C. F. Ellis P. D. Dudbridge F. Zwaginga J. J. Watkins N. A. van der Schoot C. E. Ouwehand W. H. (2007). Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 109, 3260– 3269 10.1182/blood-2006-07-036269 17192395 PMC6485507 · DOI
- Markovich D. Murer H. (2004). The SLC13 gene family of sodium sulphate/carboxylate cotransporters. Pflugers Arch. 447, 594– 602 10.1007/s00424-003-1128-6 12915942 · DOI
- Oswald S. Grube M. Siegmund W. Kroemer H. K. (2007). Transporter-mediated uptake into cellular compartments. Xenobiotica 37, 1171– 1195 10.1080/00498250701570251 17968742 · DOI
- Pajor A. M. (2006). Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. Pflugers Arch. 451, 597– 605 10.1007/s00424-005-1487-2 16211368 PMC1866268 · DOI
- Peti-Peterdi J. Kang J. J. Toma I. (2008). Activation of the renal renin-angiotensin system in diabetes – new concepts. Nephrol. Dial. Transplant. 23, 3047– 3049 10.1093/ndt/gfn377 18644796 PMC2720812 · DOI
- Regard J. B. Sato I. T. Coughlin S. R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell 135, 561– 571 10.1016/j.cell.2008.08.040 18984166 PMC2590943 · DOI
- Robben J. H. Fenton R. A. Vargas S. L. Schweer H. Peti-Peterdi J. Deen P. M. Milligan G. (2009). Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 76, 1258– 1267 10.1038/ki.2009.360 19776718 · DOI
- Rogers N. M. Matthews T. J. Kausman J. Y. Kitching A. R. Coates P. T. (2009). Review article: kidney dendritic cells: their role in homeostasis, inflammation and transplantation. Nephrology (Carlton) 14, 625– 635 10.1111/j.1440-1797.2009.01200.x 19796021 · DOI
- Rohrwasser A. Morgan T. Dillon H. F. Zhao L. Callaway C. W. Hillas E. Zhang S. Cheng T. Inagami T. Ward K. Terreros D. A. Lalouel J. M. (1999). Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34, 1265– 1274 10601129
- Rubic T. Lametschwandtner G. Jost S. Hinteregger S. Kund J. Carballido-Perrig N. Schwarzler C. Junt T. Voshol H. Meingassner J. G. Mao X. Werner G. Rot A. Carballido J. M. (2008). Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261– 1269 10.1038/ni.1657 18820681 · DOI · Paper page
- Sadagopan N. Li W. Roberds S. L. Major T. Preston G. M. Yu Y. Tones M. A. (2007). Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am. J. Hypertens. 20, 1209– 1215 17954369
- Sakai N. Wada T. Furuichi K. Iwata Y. Yoshimoto K. Kitagawa K. Kokubo S. Kobayashi M. Hara A. Yamahana J. Okumura T. Takasawa K. Takeda S. I. Yoshimura M. Kida H. Yokoyama H. (2005). Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am. J. Kidney Dis. 45, 54– 65 10.1053/j.ajkd.2004.08.039 15696444 · DOI
- Schweda F. Friis U. Wagner C. Skott O. Kurtz A. (2007). Renin release. Physiology 22, 310– 319 10.1152/physiol.00024.2007 17928544 · DOI
- Steckelings U. M. Rompe F. Kaschina E. Unger T. (2009). The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam. Clin. Pharmacol. 23, 693– 703 10.1111/j.1472-8206.2009.00780.x 19817870 · DOI
- Suzaki Y. Prieto-Carrasquero M. C. Kobori H. (2006). Intratubular renin-angiotensin system in hypertension. Curr. Hypertens. Rev. 2, 151– 157 10.2174/157340206776877325 19789728 PMC2752977 · DOI
- Vargas S. L. Toma I. Kang J. J. Meer E. J. Peti-Peterdi J. (2009). Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J. Am. Soc. Nephrol. 20, 1002– 1011 10.1681/ASN.2008070740 19389848 PMC2678039 · DOI
- Weinberg J. M. Venkatachalam M. A. Roeser N. F. Nissim I. (2000). Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl. Acad. Sci. U.S.A. 97, 2826– 2831 10.1073/pnas.97.6.2826 10717001 PMC16014 · DOI
- Wittenberger T. Schaller H. C. Hellebrand S. (2001). An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J. Mol. Biol. 307, 799– 813 10.1006/jmbi.2001.4520 11273702 · DOI
- Authors
- Ariza, A. C., Deen, P. M. T., & Robben, J. H.
- Affiliations
- Radboud University Nijmegen (NL)
- Corresponding author
- Robben, Joris Hubertus
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 22-22
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC3355999
- OpenAlex
- W2138027442
- Cited by
- 211
- References
- 43
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 13 · 2021: 22 · 2020: 15 · 2019: 15 · 2018: 21 · 2017: 18 · 2016: 14 · 2015: 10 · 2014: 7 · 2013: 4 · 2012: 4
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- European Commission (201590)
- Nierstichting (KJPB 09.012)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (865.07.002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- succinate receptor, GPR91, SUCNR1, G protein-coupled receptors, succinic acid, metabolic stress, oxidative stress, hypertension, diabetic nephropathy, diabetic retinopathy, renin-angiotensin system, renal fibrosis, metabolic syndrome, diabetes mellitus, immune cell recruitment, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review